Skip to main content
Clinical Trials/NL-OMON32007
NL-OMON32007
Recruiting
Not Applicable

Expiratory airflow limitation in subjects with obesity - Obesity and EF

Medisch Centrum Alkmaar0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
obesity overweight
Sponsor
Medisch Centrum Alkmaar
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Medisch Centrum Alkmaar

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria obese population:;Male/female, age 25\-60
  • BMI (body mass index) 30\-40 kg/m2
  • Non or ex smokers with \< 10 packyears;Inclusion criteria control population:;Male/female, age 25\-60
  • BMI (body mass index) 18\.5\-25 kg/m2
  • Non or ex smokers with \<10 packyears

Exclusion Criteria

  • COPD (FEV1/IVC\<0\.70\)
  • reversibility \>9% in FEV1 (400 microgram salbutamol)
  • other significant neuromuscular, cardiac or lung disease;Exclusie criteria controle population:
  • COPD (FEV1/FVC\<70\)
  • any other significant neuromuscular, cardial of pulmonary disease
  • reversibility \>9% in FEV1 (400 microgram salbutamol);Exclusion criteria control population:
  • No COPD (FEV1/FVC\<70\)
  • No other significant neuromuscular, cardiac or lung disease
  • No reversibility \>9% in FEV1 (400 microgram salbutamol)

Outcomes

Primary Outcomes

Not specified

Similar Trials